AVDL - Avadel Pharmaceuticals plc's (AVDL) CEO Gregory Divis on Q4 2021 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL) Q4 2021 Earnings Conference Call March 17, 2022 8:30 A.M. ET Company Participants Brandi Robinson - Senior Vice President, Corporate Affairs Gregory Divis - Chief Executive Officer Douglas Williamson - Chief Medical Officer Tom McHugh - Chief Financial Officer Richard Kim - Chief Commercial Officer Conference Call Participants Christopher Howerton - Jefferies David Amsellem - Piper Sandler & Co. Ami Fadia - Needham & Co. Paul Matteis - Stifel Oren Livnat - H.C. Wainwright & Co. LLC Matthew Kaplan - Ladenburg Thalmann & Co. Inc. Robin Garner - Craig Hallum Adam Evertts - LifeSci Capital, LLC Jason Gerberry - Bank of America Securities, Inc. Presentation Operator Greetings, and welcome to the Avadel Pharmaceuticals Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal remarks. As a reminder, this conference is being
For further details see:
Avadel Pharmaceuticals plc's (AVDL) CEO Gregory Divis on Q4 2021 Results - Earnings Call Transcript